The study medicine is an immunotherapy, which means it is designed to stimulate the body’s immune system to help slow or stop the return and/or spread of cancer. While surgery is an important part of cancer care, the healing process after surgery can make it difficult for the immune system to work as well as it should. The study medicine may be able to help the immune system do a better job targeting cancer cells. It is given as a one-time injection directly into your bladder muscle right after TURBT.
Investigational means the study medication is not approved by regulatory authorities like the US Food and Drug Administration (FDA), and it can only be used in clinical research studies like the LAUREL study.